324 related articles for article (PubMed ID: 9420278)
21. In vitro activities of benzimidazole D- and L-ribonucleosides against herpesviruses.
Williams SL; Hartline CB; Kushner NL; Harden EA; Bidanset DJ; Drach JC; Townsend LB; Underwood MR; Biron KK; Kern ER
Antimicrob Agents Chemother; 2003 Jul; 47(7):2186-92. PubMed ID: 12821466
[TBL] [Abstract][Full Text] [Related]
22. Interaction of the putative human cytomegalovirus portal protein pUL104 with the large terminase subunit pUL56 and its inhibition by benzimidazole-D-ribonucleosides.
Dittmer A; Drach JC; Townsend LB; Fischer A; Bogner E
J Virol; 2005 Dec; 79(23):14660-7. PubMed ID: 16282466
[TBL] [Abstract][Full Text] [Related]
23. An epistatic relationship between the viral protein kinase UL97 and the UL133-UL138 latency locus during the human cytomegalovirus lytic cycle.
Li G; Rak M; Nguyen CC; Umashankar M; Goodrum FD; Kamil JP
J Virol; 2014 Jun; 88(11):6047-60. PubMed ID: 24623439
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of Human Cytomegalovirus pUL89 Terminase Subunit Blocks Virus Replication and Genome Cleavage.
Wang Y; Mao L; Kankanala J; Wang Z; Geraghty RJ
J Virol; 2017 Feb; 91(3):. PubMed ID: 27881652
[TBL] [Abstract][Full Text] [Related]
25. A point mutation in the human cytomegalovirus DNA polymerase gene selected in vitro by cidofovir confers a slow replication phenotype in cell culture.
Cihlar T; Fuller MD; Mulato AS; Cherrington JM
Virology; 1998 Sep; 248(2):382-93. PubMed ID: 9721246
[TBL] [Abstract][Full Text] [Related]
26. Comparison of Cytomegalovirus Terminase Gene Mutations Selected after Exposure to Three Distinct Inhibitor Compounds.
Chou S
Antimicrob Agents Chemother; 2017 Nov; 61(11):. PubMed ID: 28827420
[TBL] [Abstract][Full Text] [Related]
27. A mutation in the DNA polymerase accessory factor of herpes simplex virus 1 restores viral DNA replication in the presence of raltegravir.
Zhou B; Yang K; Wills E; Tang L; Baines JD
J Virol; 2014 Oct; 88(19):11121-9. PubMed ID: 25008933
[TBL] [Abstract][Full Text] [Related]
28. In vitro evaluation of current and novel antivirals in combination against human cytomegalovirus.
O'Brien MS; Markovich KC; Selleseth D; DeVita AV; Sethna P; Gentry BG
Antiviral Res; 2018 Oct; 158():255-263. PubMed ID: 30153445
[TBL] [Abstract][Full Text] [Related]
29. New functional domains of human cytomegalovirus pUL89 predicted by sequence analysis and three-dimensional modelling of the catalytic site DEXDc.
Champier G; Hantz S; Couvreux A; Stuppfler S; Mazeron MC; Bouaziz S; Denis F; Alain S
Antivir Ther; 2007; 12(2):217-32. PubMed ID: 17503664
[TBL] [Abstract][Full Text] [Related]
30. The novel anticytomegalovirus compound AIC246 (Letermovir) inhibits human cytomegalovirus replication through a specific antiviral mechanism that involves the viral terminase.
Goldner T; Hewlett G; Ettischer N; Ruebsamen-Schaeff H; Zimmermann H; Lischka P
J Virol; 2011 Oct; 85(20):10884-93. PubMed ID: 21752907
[TBL] [Abstract][Full Text] [Related]
31. Design, synthesis, and antiviral evaluation of 2-substituted 4,5-dichloro- and 4,6-dichloro-1-beta-D-ribofuranosylbenzimidazoles as potential agents for human cytomegalovirus infections.
Zou R; Drach JC; Townsend LB
J Med Chem; 1997 Feb; 40(5):802-10. PubMed ID: 9057867
[TBL] [Abstract][Full Text] [Related]
32. UL69 of human cytomegalovirus, an open reading frame with homology to ICP27 of herpes simplex virus, encodes a transactivator of gene expression.
Winkler M; Rice SA; Stamminger T
J Virol; 1994 Jun; 68(6):3943-54. PubMed ID: 8189530
[TBL] [Abstract][Full Text] [Related]
33. Design, synthesis, and biological evaluation of tricyclic nucleosides (dimensional probes) as analogues of certain antiviral polyhalogenated benzimidazole ribonucleosides.
Zhu Z; Lippa B; Drach JC; Townsend LB
J Med Chem; 2000 Jun; 43(12):2430-7. PubMed ID: 10882370
[TBL] [Abstract][Full Text] [Related]
34. Open reading frame UL26 of human cytomegalovirus encodes a novel tegument protein that contains a strong transcriptional activation domain.
Stamminger T; Gstaiger M; Weinzierl K; Lorz K; Winkler M; Schaffner W
J Virol; 2002 May; 76(10):4836-47. PubMed ID: 11967300
[TBL] [Abstract][Full Text] [Related]
35. Activities of benzimidazole D- and L-ribonucleosides in animal models of cytomegalovirus infections.
Kern ER; Hartline CB; Rybak RJ; Drach JC; Townsend LB; Biron KK; Bidanset DJ
Antimicrob Agents Chemother; 2004 May; 48(5):1749-55. PubMed ID: 15105130
[TBL] [Abstract][Full Text] [Related]
36. PD0084430: a non-nucleoside inhibitor of human cytomegalovirus replication in vitro.
Meyer AL; Bruening EE; Dunkle WE; Booth RJ; Steinbaugh BA; Vara Prasad JV
Antiviral Res; 2001 Dec; 52(3):289-300. PubMed ID: 11675146
[TBL] [Abstract][Full Text] [Related]
37. Antagonistic Relationship between Human Cytomegalovirus pUL27 and pUL97 Activities during Infection.
Bigley TM; Reitsma JM; Terhune SS
J Virol; 2015 Oct; 89(20):10230-46. PubMed ID: 26223645
[TBL] [Abstract][Full Text] [Related]
38. Studies designed to increase the stability and antiviral activity (HCMV) of the active benzimidazole nucleoside, TCRB.
Townsend LB; Gudmundsson KS; Daluge SM; Chen JJ; Zhu Z; Koszalka GW; Boyd L; Chamberlain SD; Freeman GA; Biron KK; Drach JC
Nucleosides Nucleotides; 1999; 18(4-5):509-19. PubMed ID: 10432642
[TBL] [Abstract][Full Text] [Related]
39. Synthesis and antiviral evaluation of trisubstituted indole N-nucleosides as analogues of 2,5,6-trichloro-1-(beta-D-ribofuranosyl)benzimidazole (TCRB).
Chen JJ; Wei Y; Drach JC; Townsend LB
J Med Chem; 2000 Jun; 43(12):2449-56. PubMed ID: 10882372
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of ganciclovir-susceptible and -resistant human cytomegalovirus clinical isolates by the benzimidazole L-riboside 1263W94.
McSharry JJ; McDonough A; Olson B; Talarico C; Davis M; Biron KK
Clin Diagn Lab Immunol; 2001 Nov; 8(6):1279-81. PubMed ID: 11687477
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
